Bessemer Group Inc. Acquires 2,030 Shares of Integra LifeSciences Holdings Corporation (IART)

Bessemer Group Inc. boosted its position in Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 7.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,230 shares of the company’s stock after buying an additional 2,030 shares during the period. Bessemer Group Inc.’s holdings in Integra LifeSciences Holdings Corporation were worth $2,422,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Integra LifeSciences Holdings Corporation by 5.9% in the second quarter. Vanguard Group Inc. now owns 2,408,001 shares of the company’s stock worth $192,111,000 after buying an additional 133,775 shares during the period. BlackRock Fund Advisors increased its position in shares of Integra LifeSciences Holdings Corporation by 8.6% in the third quarter. BlackRock Fund Advisors now owns 2,165,730 shares of the company’s stock worth $178,781,000 after buying an additional 171,412 shares in the last quarter. Capital Research Global Investors increased its position in shares of Integra LifeSciences Holdings Corporation by 78.9% in the third quarter. Capital Research Global Investors now owns 914,000 shares of the company’s stock worth $75,451,000 after buying an additional 403,113 shares in the last quarter. Victory Capital Management Inc. acquired a new position in shares of Integra LifeSciences Holdings Corporation during the third quarter worth $63,680,000. Finally, BlackRock Institutional Trust Company N.A. increased its position in shares of Integra LifeSciences Holdings Corporation by 1.6% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 738,194 shares of the company’s stock worth $60,938,000 after buying an additional 11,484 shares in the last quarter. 44.37% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Integra LifeSciences Holdings Corporation (NASDAQ:IART) remained flat at $42.85 during mid-day trading on Tuesday. The stock had a trading volume of 67,532 shares. The company has a market cap of $3.20 billion, a P/E ratio of 55.79 and a beta of 0.80. The company’s 50 day moving average is $49.05 and its 200-day moving average is $74.74. Integra LifeSciences Holdings Corporation has a 1-year low of $40.77 and a 1-year high of $88.86.

“Bessemer Group Inc. Acquires 2,030 Shares of Integra LifeSciences Holdings Corporation (IART)” was published by sleekmoney and is owned by of sleekmoney. If you are reading this story on another website, it was illegally copied and republished in violation of United States & international copyright legislation. The correct version of this story can be viewed at http://sleekmoney.com/bessemer-group-inc-acquires-2030-shares-of-integra-lifesciences-holdings-corporation-iart/1660241.html.

A number of brokerages have recently weighed in on IART. Zacks Investment Research upgraded Integra LifeSciences Holdings Corporation from a “hold” rating to a “buy” rating and set a $48.00 price target on the stock in a report on Thursday, January 5th. RBC Capital Markets reiterated a “sector perform” rating and set a $46.00 price target (down previously from $85.00) on shares of Integra LifeSciences Holdings Corporation in a report on Friday, January 13th. Oppenheimer Holdings, Inc. reiterated a “buy” rating on shares of Integra LifeSciences Holdings Corporation in a report on Wednesday, January 11th. TheStreet upgraded Integra LifeSciences Holdings Corporation from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 27th. Finally, Barclays PLC reiterated an “equal weight” rating and set a $42.00 price target (down previously from $84.00) on shares of Integra LifeSciences Holdings Corporation in a report on Friday, January 13th. Four analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $47.15.

Integra LifeSciences Holdings Corporation Company Profile

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties.

5 Day Chart for NASDAQ:IART

Want to see what other hedge funds are holding IART? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integra LifeSciences Holdings Corporation (NASDAQ:IART).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/bessemer-group-inc-acquires-2030-shares-of-integra-lifesciences-holdings-corporation-iart/1660241.html

Receive News & Ratings for Integra LifeSciences Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *